药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02359 药明康德

已收盘 12-19 16:08:06

103.800

+1.500

+1.47%

最高106.100	最低102.300	成交量1,173万
今开102.300	昨收102.300	日振幅3.71%
总市值3,097亿	流通市值529.88亿	总股本29.84亿
成交额12.21亿	换手率2.30%	流通股本5.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":103.8,"timestamp":1766131686007,"preClose":102.3,"halted":0,"volume":11728614,"delay":0,"floatShares":510476909,"shares":2984000000,"eps":3.0334929927479846,"marketStatus":"已收盘","change":1.5,"latestTime":"12-19 16:08:06","open":102.3,"high":106.1,"low":102.3,"amount":1221330242,"amplitude":0.037146,"askPrice":103.8,"askSize":210600,"bidPrice":103.7,"bidSize":20300,"shortable":3,"etf":0,"ttmEps":5.147496257181985,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":102.3,"dividendRate":0.014004,"openAndCloseTimeList":[[1766107800000,1766116800000],[1766120400000,1766131200000]],"volumeRatio":3.64278,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":92.47,"timestamp":1766127600000,"preClose":90.59,"halted":0,"volume":46376100,"delay":0,"premium":"+1.50"}},"requestUrl":"/m/hq/s/02359/wiki","defaultTab":"wiki","newsList":[{"id":"2592685091","title":"12月19日药明康德现10笔大宗交易 机构净买入2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592685091","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592685091?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:54","pubTimestamp":1766138065,"startTime":"0","endTime":"0","summary":"证券之星消息，12月19日药明康德发生大宗交易，交易数据如下：近三个月该股共发生42笔大宗交易，合计成交19.75万手，折价成交37笔。该股近期无解禁股上市。截至2025年12月19日收盘，药明康德报收于92.47元，上涨2.08%，换手率1.88%，成交量46.38万手，成交额43.16亿元。该股近半年内有股东持股变动，合计净减持4133.67万股，股东增减持明细如下表：该股最近90天内共有22家机构给出评级，买入评级21家，增持评级1家；过去90天内机构目标均价为129.36。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/19/20251219396505.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/19/20251219396505.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251219/31878013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","LU1997245094.SGD","BK1583","02359","LU1997244956.HKD","LU2045819591.USD","LU0052750758.USD","LU1934453819.USD","LU1046422090.SGD","603259","LU1969619763.USD","LU0320764599.SGD","BK1141","LU2495084118.USD","LU2488822045.USD","LU2242644610.SGD","LU1808992512.USD","BK1576","LU2125910500.SGD","LU0456842615.SGD","LU1979443071.USD","LU0708995583.HKD","LU2328871848.SGD","LU1997245177.USD"],"gpt_icon":0},{"id":"2592415986","title":"创新药板块观察：沉寂后的“大招”，估值修复行情启动？","url":"https://stock-news.laohu8.com/highlight/detail?id=2592415986","media":"投资者研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592415986?lang=zh_cn&edition=full","pubTime":"2025-12-19 15:08","pubTimestamp":1766128104,"startTime":"0","endTime":"0","summary":"12月19日，A股创新药板块迎来久违的集体反弹。不过，也应清醒认识到，创新药板块本身具有高波动性，受研发进展、临床数据、政策节奏、市场竞争等多重因素影响，单日大涨并不等同于趋势性反转，更多应视为政策驱动下的估值修复启动信号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219152804a6b5f938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219152804a6b5f938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1576","LU0052750758.USD","LU1046422090.SGD","LU0708995583.HKD","02359","LU2045819591.USD","LU2125910500.SGD","BK1161","03347","06978","LU2242644610.SGD","BK1141","LU0320764599.SGD","BK1583"],"gpt_icon":0},{"id":"2592159839","title":"FDA质量警报频响 药明康德如何成为“零缺陷”通关达人？","url":"https://stock-news.laohu8.com/highlight/detail?id=2592159839","media":"宿迁网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592159839?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:28","pubTimestamp":1766111305,"startTime":"0","endTime":"0","summary":"2025年3月，药明康德常州与泰兴两个原料药基地相继以零缺陷通过FDA检查，未收到任何“483表格”，再次印证了其质量体系的可靠性。除了严控质量，药明康德的高效执行也备受认可。药明康德凭借其全球化CRDMO网络启动跨时区协作，最终准时交付高质量报告，成为推动客户达成交易的重要助力。净利润增速显著高于营收增速，充分体现了药明康德业务结构优化与运营效率提升已转化为实际盈利增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219130236a6b58371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219130236a6b58371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","02359","LU2125910500.SGD","BK1583","LU0708995583.HKD","LU2045819591.USD","LU1046422090.SGD","LU0320764599.SGD","BK1576","BK1141","LU2242644610.SGD"],"gpt_icon":0},{"id":"2592139047","title":"医药外包概念普遍走高 药明生物(02269)涨6.11% 机构看好看好CXO在业绩和估值端迎来双重修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139047","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139047?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:26","pubTimestamp":1766111188,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念普遍走高，药明生物 涨6.11%，凯莱英升5.52%，康龙化成升4.69%，泰格医药升3.8%，维亚生物升3.72%，药明康德涨3.32%。世纪证券此前研报指出，本周NDAA法案落地，地缘风险趋于缓和。CXO业绩和新增订单开始好转，本周市场开始关注临床前安评试验资产食蟹猴。该机构认为CXO作为创新药产业链上游，行业经历过完整周期，有望受益于国产创新药竞争力提升带来的景气度回升，看好CXO在业绩和估值端迎来双重修复。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971871","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","LU0516422366.SGD","LU0348825331.USD","BK1521","BK1574","BK1161","IE00B0JY6N72.USD","LU0039217434.USD","BK1583","LU0819121731.USD","LU0979878070.USD","02359","LU0456827905.SGD","LU1794554557.SGD","LU2045819591.USD","LU1720050803.USD","02269","LU0052750758.USD","LU3063872942.SGD","LU0359201612.USD","01873","09939","LU0043850808.USD","BK1610","159938","LU1046422090.SGD","LU0051755006.USD","03347","06821","LU0320764599.SGD","CXO","LU1880383366.USD","SG9999002463.SGD","BK1589","LU2242644610.SGD","BK1576","LU0516422440.USD","LU2125910500.SGD","LU0140636845.USD","LU0417516902.SGD","LU0516423174.USD","LU0823426480.USD","SG9999002562.SGD","LU1242518931.SGD","LU0708995583.HKD","LU0516423091.SGD","03759","LU0348735423.USD","BK1191","LU0181495838.USD"],"gpt_icon":0},{"id":"2592890154","title":"12月8日增减持汇总：西藏药业等3股增持 药明康德等11股减持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2592890154","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592890154?lang=zh_cn&edition=full","pubTime":"2025-12-18 21:59","pubTimestamp":1766066340,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　据统计，12月18日，盘后大中矿业、四川路桥、西藏药业披露增持情况。包括立达信、药明康德、飞龙股份、瑞晨环保、蠡湖股份、君实生物、奕东电子、华海诚科、博硕科技、安联锐视、大中矿业在内的11家A股上市公司披露减持情况。\n\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-12-18/doc-inhcfvmc8319448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0052750758.USD","LU0708995583.HKD","LU0320764599.SGD","603259","LU1997244956.HKD","LU2242644610.SGD","BK1141","600211","LU2488822045.USD","BK0216","BK0033","LU1046422090.SGD","02359","LU2495084118.USD","BK1583","BK1576","LU1808992512.USD","LU1997245094.SGD","LU2045819591.USD","LU1934453819.USD","LU2125910500.SGD","LU1979443071.USD","BK0239","LU1997245177.USD","LU1969619763.USD","LU0456842615.SGD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2592710089","title":"12月18日药明康德现10笔大宗交易 机构净买入2.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592710089","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592710089?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:52","pubTimestamp":1766051523,"startTime":"0","endTime":"0","summary":"证券之星消息，12月18日药明康德发生大宗交易，交易数据如下：近三个月该股共发生32笔大宗交易，合计成交16.75万手，折价成交27笔。该股近期无解禁股上市。截至2025年12月18日收盘，药明康德报收于90.59元，上涨0.0%，换手率1.16%，成交量28.65万手，成交额26.09亿元。该股近半年内有股东持股变动，合计净减持1182.79万股，股东增减持明细如下表：该股最近90天内共有22家机构给出评级，买入评级21家，增持评级1家；过去90天内机构目标均价为129.36。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800027367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2045819591.USD","LU2242644610.SGD","LU0708995583.HKD","LU2328871848.SGD","LU1934453819.USD","BK1576","LU2125910500.SGD","LU1997244956.HKD","LU0456842615.SGD","02359","BK1583","LU1979443071.USD","LU2488822045.USD","603259","BK1141","LU1997245177.USD","BK0216","LU0320764599.SGD","LU1997245094.SGD","LU2495084118.USD","LU1969619763.USD","LU0052750758.USD","LU1046422090.SGD","LU1808992512.USD"],"gpt_icon":0},{"id":"2592813972","title":"A股今日共78只个股发生大宗交易，总成交37.55亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592813972","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592813972?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:41","pubTimestamp":1766050860,"startTime":"0","endTime":"0","summary":"Wind数据显示，今日A股共78只个股发生大宗交易，总成交37.55亿元，其中民生银行、药明康德、露笑科技成交额居前，成交额依次为21.49亿元、4.3亿元、1.19亿元。成交价方面，共8只股票平价成交，3只股票溢价成交，67只股票折价成交；中航光电、中科曙光、豪威集团溢价率居前，溢价率依次为8.04%、7.92%、2.07%；聚星科技、蒙泰高新、汉仪股份折价率居前，折价率依次为29.04%、22.41%、21.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218174116a6b1ffb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218174116a6b1ffb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1141","BK1231","LU0708995583.HKD","BK1576","LU0052750758.USD","BK1583","BK1560","LU2125910500.SGD","02359","LU2242644610.SGD","LU1046422090.SGD","01988","LU2045819591.USD"],"gpt_icon":0},{"id":"2592197233","title":"每日卖空追踪 | 药明康德 12月18日卖空量成交28.96万股，卖空比例为10.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592197233?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046628,"startTime":"0","endTime":"0","summary":"药明康德北京时间12月18日，涨0.99%，卖空量成交28.96万股，较上一交易日减少60.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163442a45aa34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163442a45aa34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","BK1576","LU2045819591.USD","02359","LU0052750758.USD","LU2242644610.SGD","LU1046422090.SGD","BK1141","BK1583","LU0708995583.HKD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2592513924","title":"创新药概念逆市上扬 石药集团(01093)午后升幅扩至近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513924","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513924?lang=zh_cn&edition=full","pubTime":"2025-12-18 13:21","pubTimestamp":1766035316,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念逆市上扬，石药集团 升5.98%，药明生物升1.97%，药明合联升1.56%，先声药业升1.51%，药明康德升1.28%。开源证券指出，当前纳入医保+商保的创新药大多处于未放量以及低基数阶段，随着医保支持创新药的政策红利持续释放，我们认为纳入双目录的创新药收入有望快速提升，患者有望持续受益，同时相关创新药企也随之迎来弹性增长。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971799","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","BK1574","LU0456827905.SGD","LU0348735423.USD","LU1242518931.SGD","BK1191","LU1794554557.SGD","BK1515","SG9999002463.SGD","IE00BZ08YS42.EUR","IE0008369823.USD","LU1328277881.USD","02269","BK1610","LU1242518857.USD","LU1688375341.USD","IE00B543WZ88.USD","LU0140636845.USD","IE00BZ08YT58.USD","01093","IE00BZ08YR35.GBP","06978","LU0856984785.SGD","IE00B031HY20.USD","LU0181495838.USD","02096","LU0501845795.SGD","02359","LU0315179316.USD","LU1226287875.USD","LU1226287792.SGD","LU1807302812.USD","LU1813983027.USD","SG9999002562.SGD","LU0039217434.USD","LU3063872942.SGD","LU0052750758.USD","BK1589","LU0348825331.USD","LU0051755006.USD","LU1046422090.SGD","LU1152091754.HKD","IE00B5MMRT66.SGD","02268","LU1008478684.HKD","LU0572944931.SGD","159992","LU0307460666.USD","LU0320764599.SGD","BK1583"],"gpt_icon":0},{"id":"2592171991","title":"摩根大通增持药明康德(02359)约87.21万股 每股作价约106.32港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592171991","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592171991?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:15","pubTimestamp":1765970135,"startTime":"0","endTime":"0","summary":"12月11日，摩根大通增持药明康德(02359)87.2123万股，每股作价106.3228港元，总金额约为9272.66万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251217/20251217190717_20223.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251217/20251217190717_20223.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0234572021.USD","IE00BKDWB100.SGD","LU1808992512.USD","LU1084165304.USD","LU0310799852.SGD","IE00BZ1G4Q59.USD","LU0868494708.USD","LU1629891620.HKD","LU2125910500.SGD","IE00BJTD4N35.SGD","LU0251132253.USD","02359","IE00BKVL7J92.USD","IE00BYXW3230.USD","LU2430703251.USD","IE00BFXG1179.USD","LU0211331839.USD","LU1974910355.USD","IE00BJTD4V19.USD","LU1914381329.SGD","LU0170899867.USD","LU1997244956.HKD","LU2430703178.SGD","LU1046422090.SGD","LU1145028129.USD","LU0496365809.HKD","SG9999002224.SGD","LU0211327993.USD","LU1064131342.USD","LU2357305700.SGD","LU0203345920.USD","LU1267930490.SGD","BK1576","LU2237443549.SGD","LU0070302665.USD","LU2236285917.USD","LU0238689110.USD","IE00B775SV38.USD","LU2237443465.HKD","BK4504","IE00B1BXHZ80.USD","LU1116320901.HKD","603259","LU0964807845.USD","LU2237443978.SGD","LU0417517546.SGD","LU2417539215.USD","LU0323591593.USD","LU2242644610.SGD","LU1244550221.USD"],"gpt_icon":0},{"id":"2592103995","title":"12月17日药明康德现7笔大宗交易 机构净买入5.57亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592103995","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592103995?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:49","pubTimestamp":1765964987,"startTime":"0","endTime":"0","summary":"证券之星消息，12月17日药明康德发生大宗交易，交易数据如下：近三个月该股共发生23笔大宗交易，合计成交11.8万手，折价成交17笔。该股近期无解禁股上市。截至2025年12月17日收盘，药明康德报收于90.59元，上涨1.65%，换手率1.22%，成交量30.16万手，成交额27.07亿元。该股近半年内有股东持股变动，合计净减持1182.79万股，股东增减持明细如下表：该股最近90天内共有22家机构给出评级，买入评级21家，增持评级1家；过去90天内机构目标均价为129.36。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700028341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","BK0216","LU2488822045.USD","LU2242644610.SGD","LU0708995583.HKD","LU1997244956.HKD","BK1583","LU1979443071.USD","LU2495084118.USD","LU1808992512.USD","LU1997245177.USD","02359","LU2045819591.USD","603259","BK1576","LU0052750758.USD","LU1046422090.SGD","LU0456842615.SGD","BK1141","LU1997245094.SGD","LU2125910500.SGD","LU2328871848.SGD","LU0320764599.SGD","LU1934453819.USD"],"gpt_icon":0},{"id":"2592954803","title":"港股指数小幅高开 恒指涨0.03% 翰森制药(03692)涨1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592954803","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592954803?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:28","pubTimestamp":1765934889,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股指数小幅高开，恒指涨0.03%，国企指数涨0.12%，恒生科技指数涨0.09%。翰森制药涨1.89%，紫金矿业涨1.34%，吉利汽车涨1.13%，龙湖集团涨0.99%。跌幅方面，中国海洋石油跌1.24%，恒安国际跌1.17%，药明康德跌0.99%。锂业股走高，天齐锂业高开3.73%、赣锋锂业高开3.61%，华西证券表示，本周碳酸锂价格环比上涨，碳酸锂持续去库。蓝筹股普遍下跌，投资者年结前保持谨慎，预料指数再度考验25,000点支持，反弹阻力在26,000点水平。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971682","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01772","BK1610","LU1064131003.USD","LU1242518857.USD","600938","BK1521","513600","BK4614","LU0516423174.USD","00960","LU0149721374.USD","ZIJMY","01044","HEGIY","02833","LU0164880469.USD","LU0516423091.SGD","BK1191","00883","BK1528","LU0164865239.USD","LU0228367735.SGD","MCHmain","HHImain","002460","LU0979878070.USD","BK1589","80883","00175","002466","LU0516422952.EUR","LU0516422440.USD","LU2148510915.USD","09696","LU1242518931.SGD","LU0871576103.HKD","BK1583","LU0039217434.USD","LU0516422366.SGD","BK1238","603259","LU0531971595.HKD","03692","LU0163747925.USD","GELYY","LGFRY","LU1481107354.HKD","LU1064130708.USD","02899","601899","02359"],"gpt_icon":0},{"id":"2591612626","title":"药明康德最新公告：出售资产交易完成交割预计产生税后净利润约9.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591612626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591612626?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:43","pubTimestamp":1765791794,"startTime":"0","endTime":"0","summary":"药明康德(603259.SH)公告称，公司全资子公司上海药明康德新药开发有限公司已收到受让方支付的首期股权转让价款15.4亿元，《股权转让协议》约定的交割先决条件已满足，本次交易已完成交割，目标公司不再纳入公司合并报表范围。预计本次交易将产生税后净利润约9.6亿元，占公司最近一期（2024年度）经审计归母净利润的比例超过10%。目标公司及相关各方将按协议约定办理市监局变更登记手续，预计2025年12月31日之前完成变更登记。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603259","02359"],"gpt_icon":0},{"id":"2591625287","title":"美凯龙董秘空缺超三个月 董事长李玉鹏代行职责；药明康德28亿元出售两家子公司完成交割 首期收款15.4亿元 预计贡献净利9.6亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2591625287","media":"财中社APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591625287?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:30","pubTimestamp":1765791023,"startTime":"0","endTime":"0","summary":"1美凯龙董秘空缺超三个月 董事长李玉鹏代行职责12月15日，美凯龙发布公告，公司董事会决定由董事长李玉鹏代行董事会秘书职责，原因是董事会秘书空缺时间超过三个月。2药明康德28亿元出售两家子公司完成交割 首期收款15.4亿元 预计贡献净利9.6亿元12月15日，药明康德发布公告，关于出售资产的进展情况。2025年前三季度，药明康德实现收入328.57亿元，归母净利润120.76亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215184832a44dc87c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215184832a44dc87c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU2125910500.SGD","BK1583","LU2242644610.SGD","BK1576","LU0052750758.USD","LU2045819591.USD","LU0320764599.SGD","02359","LU1046422090.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2591252306","title":"贝莱德（BlackRock）对药明康德的多头持仓比例降至4.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591252306","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591252306?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:07","pubTimestamp":1765789671,"startTime":"0","endTime":"0","summary":"据香港交易所披露，贝莱德(BlackRock)对无锡药明康德新药开发股份有限公司-H股的多头持仓比例于2025年12月9日从5.24%降至4.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215170859a44d689f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215170859a44d689f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","BK1576","BK1583","LU0052750758.USD","BK1141","LU2045819591.USD","LU0320764599.SGD","LU0708995583.HKD","LU2242644610.SGD","02359","LU1046422090.SGD"],"gpt_icon":0},{"id":"2591252366","title":"每日卖空追踪 | 药明康德 12月15日卖空量成交9.95万股，卖空比例为3.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591252366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591252366?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787428,"startTime":"0","endTime":"0","summary":"药明康德北京时间12月15日，跌2.47%，卖空量成交9.95万股，较上一交易日减少84.29%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163422a44d40e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163422a44d40e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU0052750758.USD","LU2242644610.SGD","LU1046422090.SGD","BK1141","02359","LU0320764599.SGD","LU0708995583.HKD","LU2045819591.USD","BK1583","LU2125910500.SGD"],"gpt_icon":0},{"id":"2591616750","title":"智通AH统计|12月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2591616750","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591616750?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月15日收盘，东北电气、京城机电股份、弘业期货分列AH溢价率前三位，溢价率分别为900.00%、266.67%、265.78%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-11.03%、-0.77%、1.62%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00317","LU1504937902.USD","03143","02359","LU1522347837.USD","02338","06826","03968","03678","03750","00042","01276","LU0244354667.USD","01528","00553","00300","00187","00916","BK1562","399300","02865","00548","01988","159982","LU0823426480.USD","BK1594","LU0348827113.USD","LU1105468828.SGD","01349","01618","01812","06818","IE00B29SXG58.USD","01108","LU0886674414.USD","00638","01339","02899","01033","00038","BK1565","00177","06127","01057","02218","03606","02238"],"gpt_icon":1},{"id":"2591663796","title":"医疗与消费周报：创新药行业研发突破与市场演进的并行","url":"https://stock-news.laohu8.com/highlight/detail?id=2591663796","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591663796?lang=zh_cn&edition=full","pubTime":"2025-12-14 16:08","pubTimestamp":1765699711,"startTime":"0","endTime":"0","summary":"投资要点：近期观点1、医药指数本周关注的6个子行业只有一个录得正收益。新药分为强调全新结构的1类（创新药）与强调临床优势的2类。近年来产业规模持续扩大，从2020年约8198亿元增至2024年1.14万亿元，年均复合增长率达8.53%，预计2025年将达1.22万亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214160834a44985a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214160834a44985a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","BK1161","BK1500","BK1574","LU0307460666.USD","LU0588546209.SGD","LU1719994722.HKD","LU1969619763.USD","01276","LU1251922891.USD","LU2328871848.SGD","06978","LU1303224171.USD","BK1588","BK1583","LU1770034418.SGD","06160"],"gpt_icon":0},{"id":"2591657917","title":"医药行业周报：IN VIVO CART：BD热门赛道 早期技术具备广阔前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2591657917","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591657917?lang=zh_cn&edition=full","pubTime":"2025-12-14 00:00","pubTimestamp":1765641600,"startTime":"0","endTime":"0","summary":"核心观点：In Vivo CART赛道发展火热，2025年已经有四个MNC并购的案例发生。具体来看，In Vivo CART分为LNP和慢病毒两条技术路线，两条技术路线均具备显著特色。LNP路线来看，药物在临床前展现出了快速转染以及优异的靶向性特点，慢病毒路线中，Esobiotec等公司的BCMA In Vivo CART已经在小人群MM患者中展现非常好的早期数据。整体看，In VivoCART发展迅速，后续发展值得关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","06821","LU0052750758.USD","LU0320764599.SGD","BK1161","01801","BK1576","BK1583","LU2045819591.USD","LU2242644610.SGD","LU2125910500.SGD","BK1141","LU0708995583.HKD","02359","LU1046422090.SGD","06160","BK1574","01177"],"gpt_icon":0},{"id":"2591632904","title":"英伟达连续布局13家企业，AI制药3个方向梳理（附列表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2591632904","media":"投研大叔","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591632904?lang=zh_cn&edition=full","pubTime":"2025-12-13 19:40","pubTimestamp":1765626014,"startTime":"0","endTime":"0","summary":"今天介绍下AI制药，英伟达在过去2年投资13家AI药企，推出BioNeMo生物分子AI框架已经覆盖上百家药企，英硅智能ISM001-055进入临床III期，成为首个跨越临床II期的AI药物，从之前的布局到如今逐渐突破，商业价值正在逐渐被验证。从大叔个人来看，还有一些罕见病，由于患者少，研发不划算，而AI能快速低成本设计药物，让更多罕见病有药可治。近期热门文章HW组建医疗卫生军团，AI医疗爆发！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1988902786.USD","LU0157215616.USD","LU2505996509.AUD","IE000YTNTUN2.SGD","02359","LU2473716301.USD","03759","3NVD.UK","LU0274383776.USD","LU1496350171.SGD","LU1280957306.USD","LU2860962120.EUR","LU2592432038.USD","IE0034235188.USD","LU2420271590.USD","06127","LU0444973449.USD","IE00BJJMRY28.SGD","02196","LU0158827948.USD","SGXZ81514606.USD","NVDS","NVDD","01093","SNVD.UK","LU1642822529.SGD","02228","NVDS.UK","NVIW.SI","LU2249611893.SGD","SG9999004303.SGD","NVDA","06821","LU1914381329.SGD","IE00BDCRKT87.USD","2NVD.UK","LU0096362180.USD","LU2463028550.USD","NVDX","LU1145028129.USD","NVD2.UK","NVDY","LU0308772762.SGD","NVD","NVDU","LU2237438978.USD","LU0719512351.SGD","LU2089284900.SGD","NVD3.UK","IE000ITXATA3.USD","LU2065171311.SGD","LU2602419157.SGD","LU0320765059.SGD","LU1839511570.USD","LU2505996681.GBP","LU2191332357.HKD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":-0.0257},{"period":"1month","weight":-0.0145},{"period":"3month","weight":-0.0725},{"period":"6month","weight":0.3918},{"period":"1year","weight":0.8846},{"period":"ytd","weight":0.858}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":-0.0167},{"period":"3month","weight":-0.0394},{"period":"6month","weight":0.0836},{"period":"1year","weight":0.2836},{"period":"ytd","weight":0.2711}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.012449},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.006618},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.010471},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015053},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.001001},{"month":6,"riseRate":0.714286,"avgChangeRate":0.076679},{"month":7,"riseRate":0.714286,"avgChangeRate":0.099103},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042308},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002335},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.002939},{"month":12,"riseRate":0.714286,"avgChangeRate":0.04332}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}